Consistent to in vitro results, tumor growth and the final mean volume of the xenograft tumors (6/10) were substantially inhibited almost 50% in ZNF217 knockdown group, when compared with those in control group (8/10) (Figure 1E, P<0.05). Here, ZNF217 is linked to neoplasm.